• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX 35 DRUG-ELUTING STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX 35 DRUG-ELUTING STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZISV6-35-125-5-60-PTX
Device Problem Off-Label Use (1494)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/04/2023
Event Type  Injury  
Event Description
Per rep - 04dec2023 - they had access on the right groin.The patient already had a left fem pop bypass and already had bilateral kissing iliac artery stents.They went up and over with a 6 fr 655 high flex ansel sheath.They used a second high flex ansel sheath because the first one got crinkled (b)(4) but it worked.They went to use the second and it got ripped in half (b)(4).It may have gotten snagged on one of the prior placed stents.When they were pulling back on the sheath they realized it was pulled in half.The distal marker on the stent broke off (b)(4) along with the distal part of the high flex ansel sheath.They cut down on the left groin to pull out the foreign bodies from the sheath and the distal marker of the stent.The rep confirmed that foreign bodies from the products were successfully removed from the patient.Was patient hospitalized - already in-patient and it was an add on delay or additional procedure - surgery to remove foreign bodies addtl procedure due to product - surgery to remove foreign bodies adverse effects on patient -none other than cut down adv effects due to product -none other than cut down prefix ziv6-ptx/zisv6-ptx 3.60 are images (e.G.Angiography, us etc.) of the device and/or procedure available? n/a, yes, no -yes 3.61 was the device flushed before the procedure, as per ifu? n/a, yes, no -yes 3.62 were there any issues with flushing of the device? n/a, yes, no -no 3.63 details of the access sheath used (name, fr size,length)? - 3.64 details of the wire guide used (name, diameter, hyrdophyllic)? -035 320 road runner hydrophyllic angeld standard shaft 3.65 what approach was used to access the target site? contralateral, ipsilateral, antegrade, retrograde, other -3 entry points - main contralateral right groin access, left popliteal access and left ct access ¿ please specify for other: ¿ if contralateral, was the bifurcation angle steep? n/a, yes, no -yes 3.66 what was the target location for the stent? -left iliac - not per ifu 3.67 what artery was the stent placed in? proximal sfa, mid sfa, distal sfa, at the ostium of the profunda, p1 (proximal popliteal), other -other ¿ please specify for other: -left iliac artery 3.68 was the wire guide removed from the patient prior to advancing the delivery system? n/a, yes, no -no 3.69 if removed, was the wire guide wiped prior to advancement of the delivery system? n/a, yes, no -n/a 3.70 did the stent delivery system cross the target location? n/a, yes, no -yes 3.71 was pre-dilation performed ahead of placement of the stent? n/a, yes, no -yes 3.72 was the patient¿s anatomy difficult or altered? previous bypass, tortuous, calcified, altered, other -yes ¿ if other, please specify: -all of the above 3.73 was resistance encountered when advancing the wire guide? n/a, yes, no -yes 3.74 was resistance encountered when advancing the delivery system to the target location? n/a, yes, no -no 3.75 was resistance encountered when deploying the stent? n/a, yes, no -no 3.76 how did the physician deal with any resistance encountered? -n/a 3.77 was the stent fully deployed in the patient before removing the delivery system? n/a, yes, no -yes 3.78 after deployment did the stent show signs of any of the following: compression, fracture, deformation, constraint, elongation, other -constraint due to plaque ¿ if other, please specify: 3.79 was post-dilation performed after the placement of the stent? n/a, yes, no -no, because it was ripped in half 3.80 did any portion of the device break off? n/a, yes, no -yes ¿ if yes, please state what part: -distal marker 3.81 when did the device break? n/a, prep, advancement, deployment, withdrawal, after removal -deployment after withdrawal 3.82 thumbwheel only ¿ was the distal end of the stability sheath inside the access sheath? n/a, yes, no -yes 3.83 thumbwheel only ¿ was the retraction sheet being held during deployment.N/a, yes, no -no 3.84 did the thumbwheel spin freely or rotate without stent release or without retracting the stent retraction sheath? n/a, yes, no -yes ¿ if yes, was the stent partially deployed? n/a, yes, no -completely deployed ¿ if yes, was the partially deployed stent removed with the delivery system or was it deployed in the patient? n/a, removed, deployed -completely deployed 3.85 if removed, did any part of the stent fracture during removal of the delivery system? n/a, yes, no -yes 3.86 was the delivery system kinked or twisted during advancement or deployment? n/a, yes, no -no 3.87 please advise if and when any damage was observed on the; 3.87.1 wireguide n/a, yes, no -no ¿ prior to use, during use, post procedure -n/a 3.87.2 delivery system n/a, yes, no -distal marker ¿ prior to use, during use, post procedure -during use, when pulling out ¿ if yes, please specify (e.G.Kinked or twisted): -no 3.88 what intervention (if any) was required? -surgery 3.89 was the secondary intervention performed during the same procedure as the device failure or was it scheduled for another day? n/a, same procedure, another day -yes, same day 3.90 were any other defects (other than the complaint issue) observed on the delivery system prior to return (e.G.Kink)? n/a, yes, no -kinked and twisted ¿ please specify if yes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX 35 DRUG-ELUTING STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
MDR Report Key18380568
MDR Text Key331184409
Report Number3005580113-2023-00128
Device Sequence Number1
Product Code NIU
UDI-Device Identifier10827002384078
UDI-Public(01)10827002384078(17)250731(10)C2103895
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 12/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberZISV6-35-125-5-60-PTX
Device Lot NumberC2103895
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA12/21/2023
Distributor Facility Aware Date12/04/2023
Device Age2 MO
Event Location Hospital
Date Report to Manufacturer12/05/2023
Date Device Manufactured10/18/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age81 YR
Patient SexMale
Patient Weight76 KG
-
-